-
Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page
CMX is a train wreck
- Thread starter anonymous
- Start date
-
- Tags
- None
Yeah no it’s not. Some more than others are just cruising and are inert, while others are actively very bad at their job. Just faking it till they make it
Every single director and above should be held responsible for the DISASTER!!!! Every. Single. One. Embarrassment to the industry...
I really would like someone at CMX to tell me specifically what the issue is with the LT (rather than just a snarky response). Seems like BMS has given the LT a lot of money to buy external entities which makes me wonder if they are that bad, then why?
The issues are as follows
1. Senior LT shows favoritism only those reports and their underlings who are of Novartis origin
2. Promotion of individuals to senior drug discovery roles who have no experience and no business running drug discovery programs.
3. Advancement of targets that have no rationale for advancement in solid tumors. Targets with clear impasses in draggability, safety profiles, patient selection hypotheses given immense resources to advance solely because of belonging to Novartis' colleagues groups.
4. Constant changes in re-prioritization of program portfolios
5. Lack of clear vision for the site of CMX, even when at 100 Binney. Vision keeps changing (on indications, modalities, approaches etc).
6. Lack of willingness to feel middle management or junior employees feel heard or empowered.
7. Lack of engagement/ability to motivate, empower or otherwise maintain enthusiasm of workforce.
8. Focus on own career aspirations rather than career development of others on team.
9. Personalities of senior LT as boring as watching paint dry.
10. Lack of ability to focus Bioinformatics group to actually support programs in discovery. Bioinformatics group works on obscure academic/mechanistic questions for publication rather than helping to support biomarker ID and translationally-focused hypotheses.
Is that enough? Can keep going if you would like...
1. Senior LT shows favoritism only those reports and their underlings who are of Novartis origin
2. Promotion of individuals to senior drug discovery roles who have no experience and no business running drug discovery programs.
3. Advancement of targets that have no rationale for advancement in solid tumors. Targets with clear impasses in draggability, safety profiles, patient selection hypotheses given immense resources to advance solely because of belonging to Novartis' colleagues groups.
4. Constant changes in re-prioritization of program portfolios
5. Lack of clear vision for the site of CMX, even when at 100 Binney. Vision keeps changing (on indications, modalities, approaches etc).
6. Lack of willingness to feel middle management or junior employees feel heard or empowered.
7. Lack of engagement/ability to motivate, empower or otherwise maintain enthusiasm of workforce.
8. Focus on own career aspirations rather than career development of others on team.
9. Personalities of senior LT as boring as watching paint dry.
10. Lack of ability to focus Bioinformatics group to actually support programs in discovery. Bioinformatics group works on obscure academic/mechanistic questions for publication rather than helping to support biomarker ID and translationally-focused hypotheses.
Is that enough? Can keep going if you would like...
dayyuuum Gina. Dishing out some solid receipts.
now we just need some names or at least give us some initials so we can browse Teams and guess who the rotten apples are on the org chart.
Are you this FUCKING dense you can't figure out who the rotten apples are for yourself? No seriously? Are you a fucking baby or just part of the lazy ass leadership that wants everything done for them?
Hearing several of CMX LT is desperate to bounce…created a mess and now wants to abandon everyone on the sinking ship. Good job Gemma
Gemma will find her cat bowl and eat out the tuna